Effect of ligustrazine on hypoxic-ischemic encephalopathy in neonatal rats by regulating autophagy through the PINK1/Parkin pathway.
10.7499/j.issn.1008-8830.2302026
- Author:
Dan YANG
1
;
Gang WANG
1
;
Li-Jun YANG
1
;
Ren-Ze DUAN
1
;
Xian-Bing CHEN
1
Author Information
1. Department of Pathology, Minda Hospital of Hubei University for Nationalities, Enshi, Hubei 445000, China/Medical School, Hubei Minzu University, Enshi, Hubei 445000, China.
- Publication Type:Journal Article
- Keywords:
Hypoxic-ischemic encephalopathy;
Ligustrazine;
Mitophagy;
Neonatal rat;
PINK1/Parkin
- MeSH:
Rats;
Animals;
Hypoxia-Ischemia, Brain/metabolism*;
Animals, Newborn;
Rats, Sprague-Dawley;
Beclin-1;
Autophagy;
Ubiquitin-Protein Ligases/metabolism*;
Protein Kinases/metabolism*
- From:
Chinese Journal of Contemporary Pediatrics
2023;25(7):751-758
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVES:To study the effect of ligustrazine injection on mitophagy in neonatal rats with hypoxic-ischemic encephalopathy (HIE) and its molecular mechanism.
METHODS:Neonatal Sprague-Dawley rats, aged 7 days, were randomly divided into a sham-operation group with 8 rats, a model group with 12 rats, and a ligustrazine group with 12 rats. The rats in the model group and the ligustrazine group were used to establish a neonatal rat model of HIE by ligation of the left common carotid artery followed by hypoxia treatment, and blood vessels were exposed without any other treatment for the rats in the sham-operation group. The rats in the ligustrazine group were intraperitoneally injected with ligustrazine (20 mg/kg) daily after hypoxia-ischemia, and those in the sham-operation group and the model group were intraperitoneally injected with an equal volume of normal saline daily. Samples were collected after 7 days of treatment. Hematoxylin and eosin staining and Nissl staining were used to observe the pathological changes of neurons in brain tissue; immunohistochemical staining was used to observe the positive expression of PINK1 and Parkin in the hippocampus and cortex; TUNEL staining was used to measure neuronal apoptosis; Western blotting was used to measure the expression levels of the mitophagy pathway proteins PINK1 and Parkin and the autophagy-related proteins Beclin-1, microtubule-associated protein 1 light chain 3 (LC3), and ubiquitin-binding protein (P62).
RESULTS:Compared with the sham-operation group, the model group had a significant reduction in the number of neurons, an increase in intercellular space, loose arrangement, lipid vacuolization, and a reduction in Nissl bodies. The increased positive expression of PINK1 and Parkin, apoptosis rate of neurons, and protein expression levels of PINK1, Parkin, Beclin1 and LC3 (P<0.05) and the decreased protein expression level of P62 in the hippocampus were also observed in the model group (P<0.05). Compared with the model group, the ligustrazine group had a significant increase in the number of neurons with ordered arrangement and an increase in Nissl bodies, significant reductions in the positive expression of PINK1 and Parkin, the apoptosis rate of neurons, and the protein expression levels of PINK1, Parkin, Beclin1, and LC3 (P<0.05), and a significant increase in the protein expression level of P62 (P<0.05).
CONCLUSIONS:Ligustrazine can alleviate hypoxic-ischemic brain damage and inhibit neuronal apoptosis in neonatal rats to a certain extent, possibly by inhibiting PINK1/Parkin-mediated autophagy.
